119 related articles for article (PubMed ID: 9780490)
1. [Cervico-uterine cancer. Influence of cell and viral genes. Implications in the development of vaccines].
Gariglio P
Gac Med Mex; 1998; 134(3):297-307; discussion 309-10. PubMed ID: 9780490
[TBL] [Abstract][Full Text] [Related]
2. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
[TBL] [Abstract][Full Text] [Related]
3. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
5. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
Riou GF
Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
[TBL] [Abstract][Full Text] [Related]
7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
9. [Human papillomaviruses, cell cycle and cervical cancer].
Mougin C; Humbey O; Gay C; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
[TBL] [Abstract][Full Text] [Related]
10. Virus-associated human tumors: cervical carcinomas and papilloma viruses.
Kisseljov FL
Biochemistry (Mosc); 2000 Jan; 65(1):68-77. PubMed ID: 10702642
[TBL] [Abstract][Full Text] [Related]
11. Gene identification by cDNA arrays in HPV-positive cervical cancer.
Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
[TBL] [Abstract][Full Text] [Related]
12. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.
Narisawa-Saito M; Kiyono T
Cancer Sci; 2007 Oct; 98(10):1505-11. PubMed ID: 17645777
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade.
Ledwaba T; Dlamini Z; Naicker S; Bhoola K
Biol Chem; 2004 Aug; 385(8):671-82. PubMed ID: 15449703
[TBL] [Abstract][Full Text] [Related]
14. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
Pillai MR; Nair MK
Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
[TBL] [Abstract][Full Text] [Related]
15. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
16. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
17. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of cervical cancer and its precursors.
Heilmann V; Kreienberg R
Curr Womens Health Rep; 2002 Feb; 2(1):27-33. PubMed ID: 12112980
[TBL] [Abstract][Full Text] [Related]
19. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
20. [Oncogenes and suppressor genes in the genesis and progression of solid tumors in children].
Tonini GP; Mazzocco K; Scaruffi P
Pediatr Med Chir; 1994; 16(3):203-9. PubMed ID: 7971441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
